Association Between Toxic Effects and Survival in Patients With Cancer and Autoimmune Disease Treated With Checkpoint Inhibitor Immunotherapy.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 35797031.
- Also identified by DOI 10.1001/jamaoncol.2022.2081 and PMC identifier 9264212.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study analyzed the safety and efficacy of immune checkpoint inhibitors in patients with cancer and autoimmune disease, and examined whether immune-related toxic effects were associated with outcomes.
Medical subject headings
- Autoimmune Diseases
- Neoplasms